ST
Sushil Tiwari
About Sushil Tiwari
Data last updated:
Sushil Tiwari is an Additional Director at Xenomedix Pharmaceuticals Private Limited (since 2022). The company operates in Chemicals. Xenomedix Pharmaceuticals Private Limited reported revenue of ₹19.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 05 Sep 2022 | 2021 | ₹19.2 Lakh (FY 2025) | Active |
Board colleagues of Sushil Tiwari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sandhya Tiwari | 09111602 | Xenomedix Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sushil Tiwari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sushil Tiwari
Sushil Tiwari currently holds 1 directorship: Xenomedix Pharmaceuticals Private Limited (Additional Director, since 05 Sep 2022, revenue ₹19.2 Lakh (FY 2025)).
Sushil Tiwari was first appointed on 05 Sep 2022 as Additional Director at Xenomedix Pharmaceuticals Private Limited.
The current boards of Sushil Tiwari's companies include Sandhya Tiwari (Xenomedix Pharmaceuticals Private Limited).